## **Core Concept**
The management of breast cancer often involves a multidisciplinary approach, including surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy, depending on the stage and biological characteristics of the tumor. In the case of a 30-year-old female with unilateral breast cancer and axillary lymph node enlargement, the treatment plan post-modified radical mastectomy needs to consider the risk of recurrence and metastasis.

## **Why the Correct Answer is Right**
Given that the patient has undergone a modified radical mastectomy for unilateral breast cancer with axillary lymph node involvement, the next step in management would typically involve adjuvant therapy to reduce the risk of recurrence. Adjuvant chemotherapy is often recommended for patients with lymph node-positive breast cancer due to its ability to reduce the risk of recurrence and improve survival. This is particularly relevant for younger patients who may have a higher risk of aggressive disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option C:** This option is blank and cannot be evaluated.
- **Option D:** While not specified, if this option does not align with standard adjuvant therapy approaches for node-positive breast cancer, it would be incorrect based on current clinical guidelines.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the decision for adjuvant chemotherapy in breast cancer patients can be guided by tools like the Oncotype DX test or other genomic assays, especially in hormone receptor-positive, HER2-negative patients. However, for patients with node-positive disease, chemotherapy is often considered due to the higher risk of recurrence.

## **Correct Answer:** .

✓ Correct Answer: B. Adriamycin based chemotherapy followed by tamoxifen depending on estrogen/progesterone receptor status